News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,325 Results
Type
Article (4947)
Company Profile (100)
Press Release (214278)
Section
Business (63204)
Career Advice (98)
Deals (11981)
Drug Delivery (3)
Drug Development (34655)
Employer Resources (13)
FDA (3909)
Job Trends (3810)
News (113566)
Policy (8477)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (247)
Accelerated approval (16)
ADA (7)
Allergies (73)
Alliances (16961)
ALS (77)
Alzheimer's disease (545)
Antibody-drug conjugate (ADC) (227)
Approvals (4286)
Artificial intelligence (147)
ASCO (105)
Autoimmune disease (154)
Automation (9)
Bankruptcy (56)
Best Places to Work (3249)
BIOSECURE Act (2)
Biosimilars (134)
Biotechnology (68)
Bladder cancer (74)
Brain cancer (26)
Breast cancer (216)
Cancer (2099)
Cardiovascular disease (122)
Career advice (92)
Career pathing (3)
CAR-T (108)
CDC (2)
Celiac Disease (1)
Cell therapy (249)
Cervical cancer (16)
Clinical research (32173)
Collaboration (800)
Compensation (805)
Complete response letters (22)
COVID-19 (671)
CRISPR (30)
C-suite (478)
Cystic fibrosis (42)
Data (3453)
Depression (77)
Dermatology (36)
Diabetes (163)
Diagnostics (1003)
Digital health (8)
Diversity, equity & inclusion (2)
Drug discovery (95)
Drug pricing (12)
Drug shortages (1)
Duchenne muscular dystrophy (93)
Earnings (28865)
Editorial (3)
Employer branding (1)
Employer resources (12)
Events (39821)
Executive appointments (432)
FDA (5365)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (1)
Frontotemporal dementia (9)
Funding (484)
Gene editing (57)
Generative AI (9)
Gene therapy (128)
GLP-1 (271)
Government (655)
Grass and pollen (1)
Guidances (145)
Healthcare (2785)
Hematology (78)
HIV (33)
Huntington's disease (9)
IgA nephropathy (43)
Immunology and inflammation (56)
Immuno-oncology (36)
Indications (93)
Infectious disease (757)
Inflammatory bowel disease (85)
Inflation Reduction Act (1)
Influenza (32)
Intellectual property (117)
Interviews (13)
IPO (6392)
IRA (3)
Job creations (717)
Job search strategy (83)
JPM (5)
Kidney cancer (12)
Labor market (1)
Layoffs (37)
Leadership (2)
Legal (1522)
Liver cancer (37)
Longevity (7)
Lung cancer (348)
Lymphoma (198)
Machine learning (15)
Management (5)
Manufacturing (357)
MASH (124)
Medical device (1445)
Medtech (1463)
Mergers & acquisitions (6170)
Metabolic disorders (479)
mRNA (25)
Multiple sclerosis (76)
NASH (7)
Neurodegenerative disease (114)
Neuropsychiatric disorders (37)
Neuroscience (1135)
NextGen: Class of 2026 (893)
Non-profit (246)
Now hiring (5)
Obesity (171)
Opinion (24)
Ovarian cancer (68)
Pain (74)
Pancreatic cancer (87)
Parkinson's disease (130)
Partnered (3)
Patents (212)
Patient recruitment (303)
Peanut (22)
People (19411)
Pharmaceutical (31)
Pharmacy benefit managers (5)
Phase 1 (9405)
Phase 2 (14452)
Phase 3 (10852)
Pipeline (3900)
Policy (17)
Postmarket research (675)
Preclinical (3484)
Press Release (13)
Prostate cancer (101)
Psychedelics (4)
Radiopharmaceuticals (130)
Rare diseases (349)
Real estate (1443)
Recruiting (7)
Regulatory (8189)
Reports (12)
Research institute (292)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (6)
RSV (17)
Schizophrenia (123)
Series A (84)
Series B (64)
Service/supplier (3)
Sickle cell disease (34)
Spinal muscular atrophy (48)
Sponsored (9)
Startups (1029)
State (1)
Stomach cancer (2)
Supply chain (28)
Tariffs (7)
Vaccines (207)
Venture capital (13)
Weight loss (50)
Women's health (18)
Worklife (1)
Date
Last 7 days (190)
Last 30 days (940)
Last 365 days (11143)
2026 (5567)
2025 (11165)
2024 (12954)
2023 (14942)
2022 (19601)
2021 (20837)
2020 (18214)
2019 (11689)
2018 (8502)
2017 (10601)
2016 (8960)
2015 (11526)
2014 (8744)
2013 (6656)
2012 (6757)
2011 (6851)
2010 (6683)
Location
Africa (150)
Alabama (19)
Arizona (43)
Arkansas (3)
Asia (29038)
Australia (3570)
California (5177)
Canada (1173)
China (1084)
Colorado (146)
Connecticut (237)
Delaware (237)
Europe (33342)
Florida (709)
Georgia (152)
Idaho (4)
Illinois (256)
India (55)
Indiana (171)
Iowa (10)
Japan (404)
Kansas (77)
Kentucky (10)
Louisiana (4)
Maine (6)
Maryland (498)
Massachusetts (4114)
Michigan (51)
Minnesota (191)
Mississippi (1)
Missouri (24)
Montana (1)
Nebraska (7)
Nevada (28)
New Hampshire (6)
New Jersey (1804)
New Mexico (4)
New York (1595)
North Carolina (634)
Northern California (2774)
Ohio (119)
Oklahoma (6)
Oregon (11)
Pennsylvania (907)
Puerto Rico (5)
Rhode Island (4)
South America (205)
South Carolina (6)
Southern California (2049)
Tennessee (20)
Texas (567)
United States (17988)
Utah (105)
Vermont (1)
Virginia (165)
Washington D.C. (16)
Washington State (325)
Wisconsin (25)
219,325 Results for "sino biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sino Biological ProPure™ Endotoxin-Free Proteins: The “Invisible Guardian” of Biopharmaceuticals
April 1, 2026
·
2 min read
Press Releases
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Giuliana Rancic
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation in an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
February 1, 2026
·
3 min read
Press Releases
Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers
May 11, 2026
·
2 min read
Press Releases
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening
May 19, 2026
·
3 min read
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
Shanghai-based LaNova Medicines—which has captured the attention of some of the biggest Western pharmas—will be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $951 million.
July 16, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Sino Biological’s Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab’s Protein Design Study Published in Nature Communications
May 28, 2026
·
3 min read
Press Releases
The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
March 10, 2026
·
2 min read
Press Releases
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
March 3, 2026
·
3 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
January 29, 2026
·
2 min read
1 of 21,933
Next
